Literature DB >> 33122191

Ligand bias in receptor tyrosine kinase signaling.

Kelly Karl1, Michael D Paul1, Elena B Pasquale2, Kalina Hristova3.   

Abstract

Ligand bias is the ability of ligands to differentially activate certain receptor signaling responses compared with others. It reflects differences in the responses of a receptor to specific ligands and has implications for the development of highly specific therapeutics. Whereas ligand bias has been studied primarily for G protein-coupled receptors (GPCRs), there are also reports of ligand bias for receptor tyrosine kinases (RTKs). However, the understanding of RTK ligand bias is lagging behind the knowledge of GPCR ligand bias. In this review, we highlight how protocols that were developed to study GPCR signaling can be used to identify and quantify RTK ligand bias. We also introduce an operational model that can provide insights into the biophysical basis of RTK activation and ligand bias. Finally, we discuss possible mechanisms underpinning RTK ligand bias. Thus, this review serves as a primer for researchers interested in investigating ligand bias in RTK signaling.
© 2020 Karl et al.

Entities:  

Keywords:  Receptor tyrosine kinase (RTK); bias coefficient; bias plot; cell signaling; dimer stability; dimerization; ligand bias; ligand functional selectivity; mathematical modeling; phosphotyrosine signaling; protein conformation; receptor; receptor tyrosine kinase; signaling; thermodynamics

Mesh:

Substances:

Year:  2020        PMID: 33122191      PMCID: PMC7939482          DOI: 10.1074/jbc.REV120.015190

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  104 in total

Review 1.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 2.  Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

Authors:  Peter Keov; Patrick M Sexton; Arthur Christopoulos
Journal:  Neuropharmacology       Date:  2010-07-15       Impact factor: 5.250

3.  Fully quantified spectral imaging reveals in vivo membrane protein interactions.

Authors:  Christopher King; Michael Stoneman; Valerica Raicu; Kalina Hristova
Journal:  Integr Biol (Camb)       Date:  2016-01-20       Impact factor: 2.192

4.  Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.

Authors:  Chafen Lu; Li-Zhi Mi; Michael J Grey; Jieqing Zhu; Elizabeth Graef; Shigeyuki Yokoyama; Timothy A Springer
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

5.  Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells.

Authors:  Martin B Oleksiewicz; Christine Bonnesen; Anne Charlotte Hegelund; Anders Lundby; Gitte-Mai Nelander Holm; Marianne B Jensen; Jonas S Krabbe
Journal:  J Appl Toxicol       Date:  2010-10-08       Impact factor: 3.446

6.  The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations.

Authors:  Erin D Lew; Cristina M Furdui; Karen S Anderson; Joseph Schlessinger
Journal:  Sci Signal       Date:  2009-02-17       Impact factor: 8.192

7.  Differential effects of epidermal growth factor (EGF) receptor ligands on receptor binding, downstream signalling pathways and DNA synthesis in hepatocytes.

Authors:  J Ødegård; J E Sondresen; M Aasrum; I H Tveteraas; T K Guren; T Christoffersen; G H Thoresen
Journal:  Growth Factors       Date:  2018-03-27       Impact factor: 2.511

8.  EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.

Authors:  Daniel M Freed; Nicholas J Bessman; Anatoly Kiyatkin; Emanuel Salazar-Cavazos; Patrick O Byrne; Jason O Moore; Christopher C Valley; Kathryn M Ferguson; Daniel J Leahy; Diane S Lidke; Mark A Lemmon
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

9.  VEGFR-2 conformational switch in response to ligand binding.

Authors:  Sarvenaz Sarabipour; Kurt Ballmer-Hofer; Kalina Hristova
Journal:  Elife       Date:  2016-04-07       Impact factor: 8.140

10.  Agonism and antagonism at the insulin receptor.

Authors:  Louise Knudsen; Bo Falck Hansen; Pia Jensen; Thomas Åskov Pedersen; Kirsten Vestergaard; Lauge Schäffer; Blagoy Blagoev; Martin B Oleksiewicz; Vladislav V Kiselyov; Pierre De Meyts
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more
  6 in total

1.  Interactions between Ligand-Bound EGFR and VEGFR2.

Authors:  Michael D Paul; Kalina Hristova
Journal:  J Mol Biol       Date:  2021-04-20       Impact factor: 6.151

2.  Neural network strategies for plasma membrane selection in fluorescence microscopy images.

Authors:  Daniel Wirth; Alec McCall; Kalina Hristova
Journal:  Biophys J       Date:  2021-05-04       Impact factor: 3.699

3.  Ligands with different dimeric configurations potently activate the EphA2 receptor and reveal its potential for biased signaling.

Authors:  Maricel Gomez-Soler; Marina P Gehring; Bernhard C Lechtenberg; Elmer Zapata-Mercado; Alyssa Ruelos; Mike W Matsumoto; Kalina Hristova; Elena B Pasquale
Journal:  iScience       Date:  2022-02-04

4.  Location bias contributes to functionally selective responses of biased CXCR3 agonists.

Authors:  Dylan Scott Eiger; Noelia Boldizsar; Christopher Cole Honeycutt; Julia Gardner; Stephen Kirchner; Chloe Hicks; Issac Choi; Uyen Pham; Kevin Zheng; Anmol Warman; Jeffrey S Smith; Jennifer Y Zhang; Sudarshan Rajagopal
Journal:  Nat Commun       Date:  2022-10-04       Impact factor: 17.694

Review 5.  Community guidelines for GPCR ligand bias: IUPHAR review 32.

Authors:  Peter Kolb; Terry Kenakin; Stephen P H Alexander; Marcel Bermudez; Laura M Bohn; Christian S Breinholt; Michel Bouvier; Stephen J Hill; Evi Kostenis; Kirill A Martemyanov; Rick R Neubig; H Ongun Onaran; Sudarshan Rajagopal; Bryan L Roth; Jana Selent; Arun K Shukla; Martha E Sommer; David E Gloriam
Journal:  Br J Pharmacol       Date:  2022-03-27       Impact factor: 9.473

6.  New Intracellular Peptide Derived from Hemoglobin Alpha Chain Induces Glucose Uptake and Reduces Blood Glycemia.

Authors:  Renée N O Silva; Ricardo P Llanos; Rosangela A S Eichler; Thiago B Oliveira; Fábio C Gozzo; William T Festuccia; Emer S Ferro
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.